CardieX Limited (CDX.AX)
AUD 0.06
(-3.33%)
AUD 0.06
(-3.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 8.56 Million AUD | -44.05% |
| 2023 | 15.3 Million AUD | 165.38% |
| 2022 | 5.76 Million AUD | 71.94% |
| 2021 | 3.35 Million AUD | -30.06% |
| 2020 | 4.79 Million AUD | -23.41% |
| 2019 | 6.26 Million AUD | 244.45% |
| 2018 | 1.81 Million AUD | 11.41% |
| 2017 | 1.63 Million AUD | 11.54% |
| 2016 | 1.46 Million AUD | -9.68% |
| 2015 | 1.61 Million AUD | 20.21% |
| 2014 | 1.34 Million AUD | -9.94% |
| 2013 | 1.49 Million AUD | -34.88% |
| 2012 | 2.29 Million AUD | 3.52% |
| 2011 | 2.21 Million AUD | 2.53% |
| 2010 | 2.16 Million AUD | -33.5% |
| 2009 | 3.25 Million AUD | 63.62% |
| 2008 | 1.98 Million AUD | -1.61% |
| 2007 | 2.02 Million AUD | 40.51% |
| 2006 | 1.43 Million AUD | -6.62% |
| 2005 | 1.54 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 8.56 Million AUD | 0.0% |
| 2024 Q1 | 16.84 Million AUD | 10.07% |
| 2024 Q3 | 8.56 Million AUD | -49.17% |
| 2024 FY | 8.31 Million AUD | -45.66% |
| 2024 Q2 | 16.84 Million AUD | 0.0% |
| 2023 FY | 15.3 Million AUD | 165.38% |
| 2023 Q4 | 15.3 Million AUD | 0.12% |
| 2023 Q2 | 9.64 Million AUD | 0.0% |
| 2023 Q1 | 9.64 Million AUD | 67.23% |
| 2023 Q3 | 15.28 Million AUD | 58.5% |
| 2022 FY | 5.76 Million AUD | 71.94% |
| 2022 Q2 | 3.54 Million AUD | 0.0% |
| 2022 Q3 | 5.76 Million AUD | 62.56% |
| 2022 Q4 | 5.76 Million AUD | 0.0% |
| 2022 Q1 | 3.54 Million AUD | 5.77% |
| 2021 Q2 | 3.72 Million AUD | 0.0% |
| 2021 FY | 3.35 Million AUD | -30.06% |
| 2021 Q4 | 3.35 Million AUD | 0.0% |
| 2021 Q3 | 3.35 Million AUD | -9.85% |
| 2021 Q1 | 3.72 Million AUD | -22.42% |
| 2020 Q4 | 4.79 Million AUD | 0.0% |
| 2020 Q2 | 2.72 Million AUD | 0.0% |
| 2020 Q3 | 4.79 Million AUD | 75.87% |
| 2020 FY | 4.79 Million AUD | -23.41% |
| 2020 Q1 | 2.72 Million AUD | -56.45% |
| 2019 Q2 | 1.25 Million AUD | 0.0% |
| 2019 FY | 6.26 Million AUD | 244.45% |
| 2019 Q3 | 6.26 Million AUD | 398.33% |
| 2019 Q4 | 6.26 Million AUD | 0.0% |
| 2019 Q1 | 1.25 Million AUD | -30.88% |
| 2018 FY | 1.81 Million AUD | 11.41% |
| 2018 Q1 | 1.25 Million AUD | -23.02% |
| 2018 Q2 | 1.25 Million AUD | 0.0% |
| 2018 Q3 | 1.76 Million AUD | 40.87% |
| 2018 Q4 | 1.81 Million AUD | 2.73% |
| 2017 Q3 | 1.52 Million AUD | 12.3% |
| 2017 Q4 | 1.63 Million AUD | 6.86% |
| 2017 Q2 | 1.35 Million AUD | 0.0% |
| 2017 Q1 | 1.35 Million AUD | -7.05% |
| 2017 FY | 1.63 Million AUD | 11.54% |
| 2016 Q1 | 1.32 Million AUD | -18.02% |
| 2016 Q2 | 1.32 Million AUD | 0.0% |
| 2016 Q3 | 1.38 Million AUD | 4.21% |
| 2016 FY | 1.46 Million AUD | -9.68% |
| 2016 Q4 | 1.46 Million AUD | 5.72% |
| 2015 FY | 1.61 Million AUD | 20.21% |
| 2015 Q4 | 1.61 Million AUD | 2.29% |
| 2015 Q3 | 1.58 Million AUD | 9.84% |
| 2015 Q2 | 1.44 Million AUD | 0.0% |
| 2015 Q1 | 1.44 Million AUD | 6.99% |
| 2014 Q3 | 1.32 Million AUD | 7.91% |
| 2014 Q4 | 1.34 Million AUD | 1.59% |
| 2014 FY | 1.34 Million AUD | -9.94% |
| 2014 Q1 | 1.22 Million AUD | -17.85% |
| 2014 Q2 | 1.22 Million AUD | 0.0% |
| 2013 Q3 | 1.43 Million AUD | -40.6% |
| 2013 Q4 | 1.49 Million AUD | 4.25% |
| 2013 Q2 | 2.41 Million AUD | 0.0% |
| 2013 FY | 1.49 Million AUD | -34.88% |
| 2013 Q1 | 2.41 Million AUD | 5.17% |
| 2012 FY | 2.29 Million AUD | 3.52% |
| 2012 Q4 | 2.29 Million AUD | 0.0% |
| 2011 Q4 | 2.21 Million AUD | 0.0% |
| 2011 FY | 2.21 Million AUD | 2.53% |
| 2010 Q4 | 2.16 Million AUD | 0.0% |
| 2010 FY | 2.16 Million AUD | -33.5% |
| 2009 FY | 3.25 Million AUD | 63.62% |
| 2009 Q4 | 3.25 Million AUD | 0.0% |
| 2008 Q4 | 1.98 Million AUD | 0.0% |
| 2008 FY | 1.98 Million AUD | -1.61% |
| 2007 Q4 | 2.02 Million AUD | 0.0% |
| 2007 FY | 2.02 Million AUD | 40.51% |
| 2006 FY | 1.43 Million AUD | -6.62% |
| 2006 Q4 | 1.43 Million AUD | 0.0% |
| 2005 FY | 1.54 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 82.557% |
| Adherium Limited | 3.4 Million AUD | -151.333% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 42.063% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -561.493% |
| Anteris Technologies Ltd | 17.03 Million AUD | 49.749% |
| Control Bionics Limited | 2.75 Million AUD | -210.273% |
| Compumedics Limited | 22.14 Million AUD | 61.34% |
| Cochlear Limited | 904.6 Million AUD | 99.053% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -23.204% |
| Cyclopharm Limited | 13.65 Million AUD | 37.294% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -56.944% |
| Nova Eye Medical Limited | 8.55 Million AUD | -0.121% |
| HeraMED Limited | 1.5 Million AUD | -468.57% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 65.757% |
| ImpediMed Limited | 6.24 Million AUD | -37.151% |
| InhaleRx Limited | 911.41 Thousand AUD | -839.455% |
| LBT Innovations Limited | 5.5 Million AUD | -55.452% |
| Micro-X Limited | 12.63 Million AUD | 32.228% |
| Neurotech International Limited | 314.69 Thousand AUD | -2620.794% |
| OncoSil Medical Limited | 1.98 Million AUD | -332.005% |
| PolyNovo Limited | 37.04 Million AUD | 76.885% |
| Respiri Limited | 3.55 Million AUD | -140.922% |
| SomnoMed Limited | 24.78 Million AUD | 65.447% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 19.319% |
| Uscom Limited | 2.07 Million AUD | -312.925% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -209.454% |